Target intelligence / Profile preview

Bacterial 16S ribosomal RNA decoding center (16S rRNA decoding center)

Target
16S rRNA decoding center
Molecular classification
Ribosomal RNA, Ribonucleoprotein complex component
01

Overview

The bacterial 16S ribosomal RNA (rRNA) decoding center is a highly conserved region within the 30S small ribosomal subunit that plays a fundamental role in the fidelity of protein synthesis (Nature Reviews Microbiology, 2014). It is responsible for the accurate selection of aminoacyl-tRNA molecules based on the mRNA codon sequence present at the aminoacyl (A) site (PubMed, PMID: 10731133). During the decoding process, specific adenine residues (A1492 and A1493 in E. coli) flip out of the 16S rRNA helix to monitor the geometry of the codon-anticodon helix, ensuring a correct match (Science, 2001). This site is a major pharmacological target for several classes of antibiotics, including aminoglycosides and tetracyclines (StatPearls, 2023). Aminoglycosides bind directly to the decoding center, stabilizing the flipped-out conformation of the adenine residues and causing the ribosome to accept near-cognate tRNAs, which leads to lethal errors in protein synthesis (Nature, 2000). Because human mitochondrial ribosomes share structural similarities with bacterial 16S rRNA, drugs targeting this site can sometimes cause side effects such as hearing loss and kidney damage (NIH/NCBI, 2022).

Other names
16S rRNA A-site30S ribosomal subunit decoding centerDecoding region of the 30S subunitA-site of the 16S rRNA
02

Mechanism of action

Inhibition of bacterial protein synthesis through the induction of mRNA misreading or the physical blockade of aminoacyl-tRNA binding to the ribosomal A-site (Nature, 2000; StatPearls, 2023).

03

Biological functions

Protein synthesisTranslation initiation and elongationmRNA decodingtRNA selection
04

Disease associations

Infection
05

Safety considerations

OtotoxicityNephrotoxicityNeuromuscular blockadeAntibiotic resistance via 16S rRNA mutations or methylation (NIH/NCBI, 2022)
06

Interacting drugs

Gentamicin

11 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)16S rRNA methyltransferase expressionBacterial 16S rDNA sequencing

Beyond the preview

Go deeper on Bacterial 16S ribosomal RNA decoding center (16S rRNA decoding center).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 16S ribosomal RNA decoding center (16S rRNA decoding center).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call